Stevanato Group SpA
Closed
SectorHealthcare
20.8 -0.48
Overview
Share price change
24h
Min
20.42
Max
21.14
Income | -1.1M 38M |
|---|---|
Sales | 28M 302M |
P/E Sector Avg | 35.983 56.597 |
EPS | 0.16 |
Profit margin | 12.622 |
Employees | 6,010 |
EBITDA | -25M 40M |
Next Earnings | 5 Nov 2026 |
|---|
Market Cap | -19M 5.6B |
|---|---|
Previous open | 21.28 |
Previous close | 20.8 |
News Sentiment
By Acuity
50%
50%
136 / 339 Healthcare
Stevanato Group SpA Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Stevanato Group SpA Forecast
Sentiment
By Acuity
136 / 339 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.